Hypera S.A. (OTCMKTS:HYPMY – Get Free Report)’s stock price reached a new 52-week low on Thursday . The stock traded as low as $3.77 and last traded at $3.77, with a volume of 27890 shares trading hands. The stock had previously closed at $4.21.
Hypera Stock Down 10.5 %
The stock has a market cap of $2.39 billion, a price-to-earnings ratio of 9.04 and a beta of 1.04. The company has a 50 day simple moving average of $4.97 and a 200 day simple moving average of $5.28.
Hypera Company Profile
Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.
See Also
- Five stocks we like better than Hypera
- Consumer Discretionary Stocks Explained
- Microsoft Can Hit New All-Time Highs This Year – Here’s Why
- What is a support level?
- Zillow Stock’s Bull Case: Why This Recent Sell-Off Could Be a Buy
- Using the MarketBeat Dividend Tax Calculator
- IonQ’s Quantum Surge: Ride the Wave or Cash Out?
Receive News & Ratings for Hypera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hypera and related companies with MarketBeat.com's FREE daily email newsletter.
